Micro Medical Solutions — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Micro Medical Solutions is a clinical-stage medical device company targeting the high-unmet need in Critical Limb Ischemia (CLI) intervention. The company is developing an innovative pedal access platform and specialized tools to enable better below-the-knee (BTK) revascularization, aiming to prevent the cascade of events leading to amputation. Led by a seasoned CEO with a strong commercialization track record and a renowned CLI specialist as Chief Medical Officer, the company combines deep vascular device expertise with clinical insight. Its mission addresses a significant clinical and economic burden, positioning it in a large and growing peripheral artery disease market.

CardiovascularPeripheral Artery DiseaseCritical Limb Ischemia

Technology Platform

Focused on microvascular intervention, developing an innovative pedal access platform with an industry-leading small guide system for below-the-knee (BTK) revascularization, targeting long lesions and chronic total occlusions (CTOs).

Opportunities

The global CLI treatment market is large and growing, driven by diabetes and aging populations, with a high unmet need for effective minimally invasive solutions.

Successful technology could command premium pricing, achieve rapid adoption in limb salvage centers, and align with value-based care initiatives by reducing costly amputations.

The experienced leadership team is well-positioned to execute and attract strategic partnership or acquisition interest.

Risk Factors

Significant technical and clinical development risk in the notoriously challenging BTK anatomy.

Faces intense competition from large, established medtech companies and other startups.

As a pre-revenue company, it is dependent on external funding and subject to regulatory approval risks that could delay or prevent market entry.

Competitive Landscape

The peripheral vascular device market is highly competitive, dominated by large players like Boston Scientific, Medtronic, Abbott, and Philips. Several smaller companies also focus on BTK and CLI solutions, including those specializing in atherectomy, drug-coated balloons, and specialized guidewires. MMS aims to differentiate through a dedicated pedal access platform and tools for the most complex cases, a niche not fully addressed by current offerings.

More companies in Digital Health & Biotech SaaS →More companies in United States →